Delivra Health Brands Inc. DHBUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -60.04% | -57.85% | -11.29% | 0.40% | 20.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -60.04% | -57.85% | -11.29% | 0.40% | 20.19% |
| Cost of Revenue | -41.18% | -36.54% | 0.48% | 7.95% | 14.19% |
| Gross Profit | -76.40% | -79.04% | -24.58% | -6.98% | 25.93% |
| SG&A Expenses | -25.35% | -10.56% | -11.59% | -11.71% | -15.85% |
| Depreciation & Amortization | -100.00% | -- | -- | -91.80% | -11.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.24% | -31.07% | -14.88% | -10.41% | -2.01% |
| Operating Income | -223.54% | -262.80% | 30.16% | 94.63% | 254.01% |
| Income Before Tax | -239.46% | -154.90% | 49.18% | 81.14% | -67.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -239.46% | -154.90% | 49.18% | 81.14% | -67.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -239.46% | -154.90% | 49.18% | 81.14% | -67.47% |
| EBIT | -223.54% | -262.80% | 30.16% | 94.63% | 254.01% |
| EBITDA | -177.72% | -2,422.15% | -40.78% | 106.13% | 8,463.64% |
| EPS Basic | -239.17% | -155.32% | 49.46% | 82.05% | -60.00% |
| Normalized Basic EPS | -219.28% | -159.32% | 30.56% | 79.45% | 419.23% |
| EPS Diluted | -239.17% | -155.32% | 49.46% | 82.05% | -60.00% |
| Normalized Diluted EPS | -219.28% | -159.32% | 30.56% | 79.45% | 419.23% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 3.99% | -18.75% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 3.99% | -18.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |